Many Young Patients With Cancer Unaware of Fertility Preservation Options

Article

It is known that the fertility of adolescent and young adult patients with cancer can be put at risk by treatments, but little research has been conducted looking at awareness, counseling and actions in this area.

It is known that the fertility of adolescent and young adult patients with cancer can be put at risk by treatments, but little research has been conducted looking at awareness, counseling and actions in this area.

An analysis of 459 adolescent and young adult patients showed that fertility preservation counseling and action varied among patients based on sex, medical factors, insurance and child-rearing status. These findings, the authors wrote, demonstrate a need for both increased awareness of fertility preservation options and insurance coverage.

The authors cited several areas of concern. Patients without insurance and patients raising children younger than 18 years were more likely not to receive counseling regarding fertility preservation from providers than those who had no children. Further, among males, patients receiving treatment that posed little or no fertility risk were also less likely to discuss fertility preservation.

Male patients aged 18 to 20 years were more likely to report being told about, discussing and making arrangements for fertility preservation.

Male patients aged 18 to 20 years were more likely to report being told about, discussing and making arrangements for fertility preservation.

Male patients aged 18 to 20 years were more likely to report being told about, discussing and making arrangements for fertility preservation.

Female patients aged 21 to 29 years were more likely to report being told about and discussing fertility preservation.

Female patients aged 21 to 29 years were more likely to report being told about and discussing fertility preservation.

Female patients aged 21 to 29 years were more likely to report being told about and discussing fertility preservation.

Black men were far less likely to report being told about, discussing and making arrangements for fertility preservation.

Black men were far less likely to report being told about, discussing and making arrangements for fertility preservation.

Black men were far less likely to report being told about, discussing and making arrangements for fertility preservation.

Black and Hispanic women were less likely to report being told about and discussing fertility preservation.

Black and Hispanic women were less likely to report being told about and discussing fertility preservation.

Black and Hispanic women were less likely to report being told about and discussing fertility preservation.

Male patients not raising children were more likely to report making arrangements for fertility preservation.

Male patients not raising children were more likely to report making arrangements for fertility preservation.

Male patients not raising children were more likely to report making arrangements for fertility preservation.

Women not raising children were more likely to report discussing fertility preservation.

Women not raising children were more likely to report discussing fertility preservation.

Women not raising children were more likely to report discussing fertility preservation.

Male patients with private/HMO/IPA insurance were more likely to report discussing and making arrangements for fertility preservation.

Male patients with private/HMO/IPA insurance were more likely to report discussing and making arrangements for fertility preservation.

Male patients with private/HMO/IPA insurance were more likely to report discussing and making arrangements for fertility preservation.

Female patients with government insurance were far less likely to report discussing fertility preservation.

Female patients with government insurance were far less likely to report discussing fertility preservation.

Female patients with government insurance were far less likely to report discussing fertility preservation.

When it came to actually taking action, males without a college degree, males raising children younger than 18 years, and those lacking private insurance were all more likely to not make fertility preservation arrangements. Too few females made arrangements for such an analysis to be conducted.Eligible patients were part of one of seven geographically defined U.S. regions in the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program.

Patients were 15 to 39 years old when diagnosed with germ cell tumor, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia or sarcoma. Patients were diagnosed between July 1, 2007, and October 31, 2008.

Overall, 1,309 patients were recruited. Of those, 459 patients completed a baseline questionnaire six to 14 months after their diagnosis and a follow-up survey after that (15 to 35 months after diagnosis). Medical record data were abstracted for all 459 patients.

The authors highlighted differences in the discussion of and arrangements for fertility preservation between the sexes.

Females were less than half as likely as their male counterparts to report that fertility preservation options were discussed.

Further, “[m]ost striking, nearly one-third of males reported making arrangements for fertility preservation, a rate that was four to five times higher than that for females,” the authors wrote.

Differences in access and health-related reasons for patients not making arrangements for fertility preservation clarify several needs, the authors wrote.

There remains a need for lower costs, improved insurance coverage and “partnerships between cancer health care providers and fertility experts” to increase awareness.

Chart data adapted from: Shnorhavorian M, Harlan LC, Wilder Smith A, et al. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: a population-based study [published online July 27, 2015].Cancer.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content